Business Context and Reporting Period
This Form 8-K Current Report was filed by Privia Health Group, Inc. (PRVA) on July 3, 2025, covering events occurring on that date and effective July 15, 2025. The filing primarily addresses corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial disclosure relates to director compensation:
- Director Equity Grant: Lance Berberian will receive an annual equity grant of restricted stock units with a grant date fair market value of $200,000.
- Director Cash Retainer: Mr. Berberian will receive an annual cash retainer under the Non-Employee Director Compensation Program (specific amount not disclosed).
Material Changes
The Board of Directors increased its size from nine to ten directors. Lance Berberian was elected as a Class III director and appointed to the Audit Committee, effective July 15, 2025. The Board determined Mr. Berberian to be independent and met the heightened financial literacy requirements for Audit Committee service.
Guidance, Outlook, and Risks
The filing contains no management commentary on business outlook, guidance, risks, contingencies, or unusual items. It strictly reports the appointment and compensation terms of the new director.
Investor Verification Checklist
- Verify the independence status and background of the new director, Lance Berberian.
- Review the attached press release (Exhibit 99.1) for additional context on the Board's strategic rationale.
- Confirm the pro-rated calculation of the initial equity grant based on the time served until the next annual meeting.
- Note that this filing does not contain updated financial results; refer to the most recent 10-Q or 10-K for financial performance.